Tech Company Financing Transactions
Pervasis Therapeutics Funding Round
Pervasis Therapeutics secured a $2.7 million venture capital round on 3/31/2010. Backers included Polaris Partners and private investors.
Transaction Overview
Company Name
Announced On
3/31/2010
Transaction Type
Venture Equity
Amount
$2,710,000
Round
Undisclosed
Investors
Polaris Partners (Amir Nashat)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
One Kendall Square B6101
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Pervasis Therapeutics is focused on creating biologically active vascular technologies to treat significant unmet needs in cardiovascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frederic Chereau
Co-Founder
Helen Nugent
VP - Bus. Development
Margaret O'Toole
VP - Manufacturing
Jack Harvey
Browse more venture capital transactions:
Prev: 3/31/2010: Precursor Energetics venture capital transaction
Next: 3/31/2010: Agile RF venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs